Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (261-270 of 292) with videos related to

Pageof 30
Sort By:
The British Journal of Dermatology|September 27, 2005
Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemiaE Robak, J Góra-Tybor, R Kordek, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|April 18, 1983
[Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)]T Robak, E Krykowski, A Płuzańska, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|April 4, 1977
[Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications]A Mazurowa, E Krykowski, A Pluzańska, et al.
The British Journal of Dermatology|August 19, 2007
Primary cutaneous marginal zone B-cell lymphoma in a patient with chronic lymphocytic leukaemiaE Robak, D Jesionek-Kupnicka, T Robak, et al.
Blood Cancer Journal|October 3, 2015
Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemiaG Palermo, D Maisel, M Barrett, et al.
Neoplasma|July 13, 2011
Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patientsP Pluta, B Cebula-Obrzut, V Ehemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2020
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upB Eichhorst, T Robak, E Montserrat, et al.
Neoplasma|February 14, 2003
The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II studyA Wrzesien-Kus, T Robak, K Jamroziak, et al.
British Journal of Cancer|November 3, 2004
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myelomaI Hus, A Dmoszynska, J Manko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2018
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaW Jurczak, P L Zinzani, G Gaidano, et al.
Pageof 30

Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
The British Journal of Dermatology|September 27, 2005
Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemiaE Robak, J Góra-Tybor, R Kordek, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|April 18, 1983
[Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)]T Robak, E Krykowski, A Płuzańska, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|April 4, 1977
[Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications]A Mazurowa, E Krykowski, A Pluzańska, et al.
The British Journal of Dermatology|August 19, 2007
Primary cutaneous marginal zone B-cell lymphoma in a patient with chronic lymphocytic leukaemiaE Robak, D Jesionek-Kupnicka, T Robak, et al.
Blood Cancer Journal|October 3, 2015
Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemiaG Palermo, D Maisel, M Barrett, et al.
Neoplasma|July 13, 2011
Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patientsP Pluta, B Cebula-Obrzut, V Ehemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2020
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upB Eichhorst, T Robak, E Montserrat, et al.
Neoplasma|February 14, 2003
The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II studyA Wrzesien-Kus, T Robak, K Jamroziak, et al.
British Journal of Cancer|November 3, 2004
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myelomaI Hus, A Dmoszynska, J Manko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2018
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaW Jurczak, P L Zinzani, G Gaidano, et al.
Pageof 30